12 lines
1.7 KiB
Plaintext
12 lines
1.7 KiB
Plaintext
|
"研发项目","研发投入金额","研发投入费用化金额","研发投入资本化金额","研发投入占营业收入比例（%）","本期金额较上年同期变动比例（%）","情况说明"
|
|||
|
|
"冻干人用狂犬病疫苗（Vero细胞）","1599.09","","1599.09","11.88","16.44",""
|
|||
|
|
"四价流感病毒裂解疫苗（儿童）","410.69","410.69","","3.05","349.70","本报告期该项目已完成Ⅰ期临床试验，正在进行III期临床试验前期准备工作，研发投入同比增加。"
|
|||
|
|
"23价肺炎球菌多糖疫苗/13价肺炎球菌多糖结合疫苗","123.49","123.49","","0.92","20.09",""
|
|||
|
|
"冻干水痘减毒活疫苗","225.03","225.03","","1.67","-18.47",""
|
|||
|
|
"四价流感病毒裂解疫苗（高剂量）","110.64","110.64","","0.82","-92.85","本报告期该项目处于临床前研究阶段，研发投入同比减少。"
|
|||
|
|
"重组带状疱疹疫苗","168.99","168.99","","1.26","80.87","本报告期该项目处于临床前研究阶段，技术服务费研发投入同比增加。"
|
|||
|
|
"冻干人用狂犬病疫苗（MRC-5细胞）","33.77","33.77","","0.25","-55.03","本报告期该项目处于临床前研究阶段，研发投入同比增加。"
|
|||
|
|
"多价手足口病疫苗","33.77","33.77","","0.25","-63.65","本报告期该项目处于临床前研究阶段，研发投入同比增加。"
|
|||
|
|
"注射用重组人IL12/15-PDL1单纯疱疹I型溶瘤病毒注射液","33.49","33.49","","0.25","-57.64","本报告期该项目处于临床前研究阶段，研发投入同比增加。"
|
|||
|
|
"在中国3至8岁儿童中四价流感病毒裂解疫苗2针次免疫程序的探索研究","54.38","54.38","","0.40","-24.28","本报告期该项目临床研究完成，研发投入同比减少。"
|